Monte Rosa Therapeutics Balance Sheet (2020-2026) | GLUE

Balance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
357.06M367.03M320.80M138.31M103.66M112.39M54.91M51.85M47.03M59.05M236.42M99.75M108.85M125.58M380.96M78.53M69.43M208.34M129.88M678.09M
Short-term Investments (Quarter)
0.96M0.96M0.96M
Cash & Current Investments (Quarter)
357.06M367.03M320.80M138.31M103.66M113.35M55.87M52.81M47.03M59.05M236.42M99.75M108.85M125.58M380.96M78.53M69.43M208.34M129.88M678.09M
Receivables - Net (Quarter)
9.00M
Receivables - Other (Quarter)
4.05M7.66M2.17M1.15M0.29M0.51M0.60M0.84M0.59M0.17M1.41M2.37M4.96M4.60M4.61M
Receivables (Quarter)
9.84M
Prepaid Assets (Quarter)
1.23M3.48M2.60M3.20M2.90M4.57M4.44M5.69M3.88M4.14M3.29M5.54M5.85M8.43M5.12M4.80M6.50M5.59M4.48M6.72M
Current Assets (Quarter)
358.29M370.52M348.67M320.37M297.05M295.24M275.89M240.56M208.10M182.91M236.21M199.04M277.90M251.21M377.44M332.28M299.46M401.82M393.19M677.55M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
8.92M11.80M12.32M13.40M15.21M19.38M27.07M33.80M35.34M34.99M33.80M34.04M33.25M31.44M29.48M29.34M29.05M27.60M25.99M28.41M
Other Non-Current Assets (Quarter)
1.73M1.73M5.34M5.33M5.32M5.26M4.32M5.28M4.53M4.52M4.58M4.86M4.87M4.91M4.86M4.88M4.95M4.95M0.15M0.83M
Non-Current Assets (Quarter)
10.65M13.53M17.66M25.64M68.01M62.37M66.50M68.47M70.51M69.19M67.54M67.71M66.22M63.87M61.29M60.92M60.12M58.02M55.47M58.88M
Assets (Quarter)
368.94M384.05M366.33M346.00M365.06M357.60M342.39M309.03M278.62M252.10M303.75M266.75M344.11M315.08M438.73M393.20M359.59M459.84M448.66M736.43M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
0.50M9.21M10.08M6.46M7.82M9.75M14.58M10.24M5.31M5.50M14.60M6.83M12.76M3.98M17.21M16.29M5.58M17.90M26.69M7.90M
Payables (Quarter)
0.50M9.21M10.08M6.46M7.82M9.75M14.58M10.24M5.31M5.50M14.60M6.83M12.76M3.98M17.21M16.29M5.58M17.90M26.69M7.90M
Accumulated Expenses (Quarter)
4.94M3.94M3.17M4.46M6.14M5.34M3.54M5.67M6.70M7.21M8.03M
Other Accumulated Expenses (Quarter)
0.84M5.02M3.84M2.46M2.91M1.67M2.16M1.95M1.30M3.35M4.42M
Current Leases (Quarter)
2.66M3.06M3.13M2.89M2.67M2.88M3.16M3.35M3.47M3.65M3.71M3.87M4.09M4.24M4.40M4.48M
Current Deferred Revenue (Quarter)
32.32M28.53M33.60M25.11M117.23M16.86M18.41M24.79M111.33M103.64M
Total Current Liabilities (Quarter)
10.79M12.74M16.64M12.49M14.77M21.79M25.57M20.52M19.09M22.61M46.59M41.29M42.35M41.64M156.95M59.22M41.85M61.44M64.21M71.04M
Non-Current Liabilities
Pension (Quarter)
1.47M2.00M5.97M2.18M2.14M2.13M6.85M1.51M1.50M1.45M12.03M2.57M2.61M2.82M3.70M3.96M4.56M4.74M5.26M5.26M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
5.46M46.09M42.59M43.87M43.27M44.37M43.52M42.88M41.84M40.88M40.05M39.00M38.00M37.04M35.93M34.79M34.58M
Total Non-Current Liabilities (Quarter)
101.20M99.20M93.20M
Total Liabilities (Quarter)
12.26M14.74M18.81M20.13M63.01M66.51M70.98M65.30M64.96M67.58M124.50M114.23M119.44M109.62M215.80M118.04M91.51M214.00M215.60M214.51M
Shareholder's Equity
Common Equity (Quarter)
356.68M369.31M347.51M325.88M302.05M291.09M271.41M243.73M213.65M184.52M179.25M152.52M224.67M205.46M222.94M275.16M268.08M245.84M233.06M521.92M
Shareholder's Equity (Quarter)
356.68M369.31M347.51M325.88M302.05M291.09M271.41M243.73M213.65M184.52M179.25M152.52M224.67M205.46M222.94M275.16M268.08M245.84M233.06M521.92M
Liabilities and Shareholders Equity (Quarter)
368.94M384.05M366.33M346.00M365.06M357.60M342.39M309.03M278.62M252.10M303.75M266.75M344.11M315.08M438.73M393.20M359.59M459.84M448.66M736.43M
Retained Earnings (Quarter)
-1.42M-98.60M-122.03M-145.97M-2.46M-199.75M-1.75M-1.39M-297.80M-332.60M-2.72M-2.69M-428.17M-452.02M-3.36M-3.33M-404.00M-431.08M-3.83M-521.72M
Treasury Shares (Quarter)
0.42M0.30M0.26M0.22M0.19M0.16M0.12M0.09M0.29M0.02M0.24M0.01M0.01M624.000.11M0.89M0.78M0.77M0.78M1.15M